Market Overview

Why Qualigen's Stock Trading Higher Today


Qualigen Therapeutics (NASDAQ: QLGN) shares are trading higher on Wednesday, after the company signed an exclusive licensing agreement with the University of Louisville and it plans to develop its AS1411 for the treatment of coronavirus.

Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology.

Qualigen Therapeutics shares are trading up 6.12% at $5.72 at time of publication on Wednesday. The stock has a 52-week high of $31.75 and a 52-week low of $3.75.

Related Links:

UK Clears Gilead's Remdesivir For Some Coronavirus Patients

Gilead Analysts See Questionable Commercial Opportunity For Coronavirus Candidate Remdesivir


Related Articles (QLGN)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Health Care Contracts General